Impact of Neoadjuvant Approach and Tumor Response on Survival in Pancreatic Adenocarcinoma
It is hypothesized that tumor response to different neoadjuvant approaches reflects underlying tumor biology, and achieving a pathologic complete response (pCR) with single‐agent neoadjuvant may signal favorable biology.